Advertisement

Neurology

Home Neurology
Bumetanide seems effective for improving symptoms of autism spectrum disorder in young children

Bumetanide Promising for Reducing Autism Symptoms

Decrease in GABA/glutamate ratio in insular cortex tied to symptom improvement in bumetanide group
There is no significant difference in the incidence of death or disabling stroke at five years among patients with aortic stenosis at intermediate surgical risk who undergo transcatheter aortic valve replacement or surgical aortic valve replacement

Five-Year Outcomes Comparable for TAVR, Surgical AVR

For those at intermediate surgical risk, death from any cause or disabling stroke at five years did not differ
Mothers with autism face unique challenges

Mothers With Autism Face Higher Rates of Postpartum Depression

Women with autism feel misunderstood by professionals, unable to receive parenting support

January 2020 Briefing – Neurology

Here are what the editors at HealthDay consider to be the most important developments in Neurology for January 2020. This roundup includes the latest...
Among people with autism spectrum disorder

Girls May Receive First Autism Diagnosis Later Than Boys

Neurological, developmental, psychiatric disorders common in those with autism spectrum disorder
Timing of treatment start is an important predictor of disability accumulation in patients with pediatric-onset multiple sclerosis

Early Treatment Tied to Less Disability With Pediatric-Onset MS

Less disability seen among those initiating disease-modifying therapy within two years of clinical onset
Road proximity is associated with an increased incidence of specific neurologic disorders

Road Proximity Linked to Incidence of Neurologic Diseases

Incidence increased for non-Alzheimer dementia, Parkinson, Alzheimer disease, multiple sclerosis
The United States spends substantially more than any other wealthy nation on health care

U.S. Spends More on Health Care, but Has Worse Life Expectancy

Compared with 10 other wealthy nations, U.S. has lower life expectancy, higher suicide rates
Comorbidities increase the rate of all-cause

Comorbidities Tied to Higher Rates of All-Cause Admissions in MS Patients

But comorbidities not associated with increased hospitalizations related to multiple sclerosis
Suvorexant improves total sleep time in patients with probable Alzheimer disease dementia and insomnia

Suvorexant May Improve Insomnia With Alzheimer Disease

Suvorexant does not appear to worsen underlying cognitive impairment